SARS-CoV 3C-like protease (3CLpro) substrate (C-terminal KK-acid)

Ref. 3D-CRB1001502

Informations sur le produit

• Nom: SARS-CoV 3C-like protease (3CLpro) substrate (C-terminal KK-acid)
• Synonymes: H-AVLQSGFRKK-OHCoronavirus, SARS-CoV-2

Description

3CLpro are the key enzymes required by coronaviruses to replicate. They cleave polyproteins to form replicase. This makes 3CLpro a drug target for protease inhibitors with particular interest to COVID-19. For, example Paxlovid®- has been brought to market as a 3CLpro inhibitor that can be administered orally to reduce coronavirus disease 19 (COVID-19) hospitalisation. Aiming to expand on such advances, synthesis of more substrates for 3CLpro are being generated and tested for their ability to inhibit the protease activity and thus replication cycle of coronaviruses. This product is the natural substrate for 3CLpro, this makes it a useful tool as a control but also for structural manipulation to design inhibitors.

• Marque: Biosynth